This sensitive and complex issue has been brought to the center of French public life by a scandal involving a former elected official. Former senator Joël Guerriau appeared before the Paris Criminal Court on January 26 and 27, accused of having drugged MP Sandrine Josso on November 14, 2023, for the purpose of sexually assaulting her. The case contributes to the debate not only on the alleged crime but also on the behavior of political elites, the integrity of procedures, and the broader fight against chemical submission.
The Charges and Legal Stakes
Joël Guerriau, 68, is charged with administering a narcotic substance to Sandrine Josso with the intent to commit sexual assault or rape. These charges carry a maximum penalty of five years in prison and a €75,000 fine. He is also facing charges of drug possession, after police found a bag containing MDMA in his residence. This additional charge could lead to up to one year in prison and a €3,750 fine.
Guerriau, a former member of the Horizons party, has pleaded that the incident was a mistake, insisting he did not intend to drug his colleague. The defense is expected to present a toxicology expert to argue that the amount of MDMA involved would have been obvious if it had been intentionally placed in the drink.
A Political Relationship Turned Into a Courtroom Battle
The two former “political friends” have not seen each other for over a year. Their last encounter occurred during a confrontation arranged by investigators in November 2024. Guerriau is under judicial supervision and prohibited from contacting Sandrine Josso or witnesses.
Sandrine Josso, now 50, has publicly expressed the heavy emotional burden of revisiting the events. She described the experience as traumatic and has stated that the case must serve as a warning and an educational example for society.
The Night of November 14, 2023: A Suspicious Celebration
The alleged incident took place at Guerriau’s Parisian apartment in the 6th arrondissement. Sandrine Josso attended to celebrate his re-election as senator for Loire-Atlantique. The two politicians had known each other for around ten years and described their relationship as strictly professional.
However, Josso was surprised to be the only guest, especially since the meeting was originally planned for a restaurant. Shortly after arriving, she observed Guerriau handling a bag of white powder while preparing champagne.
Several details triggered her suspicion:
- The champagne had an unusual taste
- Guerriau repeatedly offered toasts and appeared unusually focused on the lighting
- He performed a “magic trick” she described as suggestive of sexual penetration
- She experienced nausea, sweating, and heart palpitations
By around 10 p.m., Josso became convinced she had been drugged. She took a taxi to the National Assembly, informed a colleague, and received medical attention upon arrival.
Toxicology and Evidence: MDMA Found in the MP’s System
The toxicology report revealed 388 ng/mL of MDMA in Josso’s blood—about twice the dose typically associated with recreational use. This finding is central to the prosecution’s claim of chemical submission.
The following day, police searched Guerriau’s home and seized:
- A 30g bag of MDMA
- €680 in cash
- Computer equipment
Further technical analysis revealed that Guerriau deleted:
- An unanswered message from Josso asking about the evening
- Texts exchanged with a woman who later identified herself as Guerriau’s mistress
His devices also showed visits to pornographic and prostitution websites, and, crucially, multiple internet searches about:
- GHB and ecstasy effects
- “Date rape drugs,” their dangers, and how to obtain them
- “Correct reactions” for victims of drug-facilitated sexual assault
The Prosecution’s Argument: Intentionality
For the prosecution, the evidence is clear: Sandrine Josso was a victim of chemical submission. Prosecutors argue that Guerriau’s online searches, months before the event, demonstrate premeditation.
In her testimony, Josso said:
“He typed the words ‘drugs and rape’ into Google, he did all that before he even saw me!”
This statement highlights the prosecution’s central claim: the act was planned in advance, not a careless mistake.
Defense Strategy: Changing Versions and a Question of Credibility
Guerriau has consistently denied any intention to drug or assault his colleague. However, his defense has shifted over time.
Initially, he claimed he had never seen the bag of MDMA found in his kitchen. Later, he stated that a colleague gave him the substance in spring 2023, which he described as a “euphoric to combat anxiety.” He also said he did not know it was narcotic.
He further explained that he poured the powder into a glass a week (later changed to the day before) the incident, but did not drink it due to medication concerns. He claimed he later served Josso from the same glass “inadvertently,” forgetting he had added the powder.
When asked about his internet searches, he said he was investigating “date rape drugs” after hearing about a possible victim through a friend, and after discussing the issue with a police officer.
Additional Allegations and Unanswered Questions
While Guerriau’s wife and colleagues testified that he never behaved inappropriately toward women, another former staffer accused him of sexual assault in May 2022. She told the investigative program Complément d’enquête that she was assaulted at his home after an evening together and described a similar modus operandi.
She did not file a complaint and was not interviewed by police, citing anonymity concerns. Guerriau has denied these accusations.
Political Fallout and the Defendant’s Silence
Following the scandal, Guerriau withdrew from parliamentary work and resigned from the Senate in September. During a court hearing in November, he appeared on crutches and mentioned upcoming surgeries in 2026.
He declined to discuss his health or the case, stating he would speak only in court and requesting respect for the presumption of innocence.
Sandrine Josso’s Response: Turning Trauma into Reform
Sandrine Josso has positioned the trial as more than a personal battle. She hopes it becomes an “educational” trial for the public.
In recent months, she has continued to introduce amendments and bills aimed at strengthening the fight against drug-facilitated sexual assault. Her stated goal is to ensure all victims receive the same treatment she did during the investigation.
“I want all victims to be treated as I was,”
she said.
“It’s my obsession.”
This trial is not only a legal battle between two public figures. It also reflects a broader national conversation about consent, power, and the protection of victims. With clear evidence of MDMA ingestion and suspicious behavior on the night of the incident, the prosecution argues that the case demonstrates premeditated intent.
The defense insists it was a mistake, but shifting explanations and deleted evidence raise questions about credibility. As the trial unfolds, it will likely influence future legal reforms and public attitudes toward drug-facilitated sexual assault in France—especially when allegations involve political elites and the highest levels of power.
